Aprea Therapeutics, Inc. (NASDAQ:APRE) Short Interest Down 34.6% in May
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) was the target of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 21,200 shares, a decrease of 34.6% from the May 15th total of 32,400 shares. Based on an average daily trading volume, of 29,200 shares, the days-to-cover […]
More Stories
8 Best Commercial Skylight Companies for US Projects (2026)
Getting commercial daylighting wrong is expensive in a way residential work rarely is. A leaking curb on a house is...
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...
The Inbetweeners 3: Release Date, Cast, Trailer, and Updates
The Inbetweeners 3 is finally coming back on the popular streaming Network, Netflix. The original four stars of the series,...
7 Essential Components of a Modern Corporate Training Tech Stack
What the seven components need to accomplish Your LMS isn’t obsolete. It may simply need to play one part in...
Climate-ready workplaces in 2026: managing heat, flooding, ice and severe weather
Irish and British workplaces are facing severe weather with increasing frequencies, from heatwares and flash flooding to ice underfoot. Preparing...
7 Best Bespoke Smoke Vents for Large and Complex Roof Openings (2026)
Picture a main contractor in Leeds coordinating a logistics warehouse where the structural grid leaves a 2,800 mm clear zone...